MIRA Pharmaceuticals Statistics
Total Valuation
MIRA has a market cap or net worth of $23.71 million. The enterprise value is $22.33 million.
Important Dates
The last earnings date was Wednesday, May 14, 2025, after market close.
Earnings Date | May 14, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
MIRA has 16.81 million shares outstanding. The number of shares has increased by 20.70% in one year.
Current Share Class | 16.81M |
Shares Outstanding | 16.81M |
Shares Change (YoY) | +20.70% |
Shares Change (QoQ) | +0.51% |
Owned by Insiders (%) | 6.54% |
Owned by Institutions (%) | 5.76% |
Float | 13.17M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 18.19 |
P/TBV Ratio | 18.19 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 12.86
Current Ratio | 12.86 |
Quick Ratio | 11.36 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -355.82% and return on invested capital (ROIC) is -226.16%.
Return on Equity (ROE) | -355.82% |
Return on Assets (ROA) | -193.30% |
Return on Invested Capital (ROIC) | -226.16% |
Return on Capital Employed (ROCE) | -622.44% |
Revenue Per Employee | n/a |
Profits Per Employee | -$2.64M |
Employee Count | 3 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +64.57% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +64.57% |
50-Day Moving Average | 1.12 |
200-Day Moving Average | 1.25 |
Relative Strength Index (RSI) | 63.61 |
Average Volume (20 Days) | 657,190 |
Short Selling Information
The latest short interest is 455,312, so 2.71% of the outstanding shares have been sold short.
Short Interest | 455,312 |
Short Previous Month | 893,323 |
Short % of Shares Out | 2.71% |
Short % of Float | 3.46% |
Short Ratio (days to cover) | 0.14 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -8.06M |
Pretax Income | -12.36M |
Net Income | -7.92M |
EBITDA | n/a |
EBIT | -8.06M |
Earnings Per Share (EPS) | -$0.50 |
Full Income Statement Balance Sheet
The company has $1.21 million in cash and n/a in debt, giving a net cash position of $1.21 million or $0.07 per share.
Cash & Cash Equivalents | 1.21M |
Total Debt | n/a |
Net Cash | 1.21M |
Net Cash Per Share | $0.07 |
Equity (Book Value) | 1.29M |
Book Value Per Share | 0.08 |
Working Capital | 1.26M |
Full Balance Sheet Cash Flow
Operating Cash Flow | -6.14M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
MIRA does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -20.70% |
Shareholder Yield | -20.70% |
Earnings Yield | -33.64% |
FCF Yield | n/a |
Analyst Forecast
The average price target for MIRA is $14.00, which is 892.91% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $14.00 |
Price Target Difference | 892.91% |
Analyst Consensus | Strong Buy |
Analyst Count | 2 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |